These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 12088676)
1. Links between innate and adaptive immunity via type I interferon. Le Bon A; Tough DF Curr Opin Immunol; 2002 Aug; 14(4):432-6. PubMed ID: 12088676 [TBL] [Abstract][Full Text] [Related]
2. Type I interferon as a link between innate and adaptive immunity through dendritic cell stimulation. Tough DF Leuk Lymphoma; 2004 Feb; 45(2):257-64. PubMed ID: 15101709 [TBL] [Abstract][Full Text] [Related]
3. Regulatory effect of IFN-kappa, a novel type I IFN, on cytokine production by cells of the innate immune system. Nardelli B; Zaritskaya L; Semenuk M; Cho YH; LaFleur DW; Shah D; Ullrich S; Girolomoni G; Albanesi C; Moore PA J Immunol; 2002 Nov; 169(9):4822-30. PubMed ID: 12391192 [TBL] [Abstract][Full Text] [Related]
4. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Le Bon A; Schiavoni G; D'Agostino G; Gresser I; Belardelli F; Tough DF Immunity; 2001 Apr; 14(4):461-70. PubMed ID: 11336691 [TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro regulation of type I IFN synthesis by synergistic effects of CD40 and type II IFN. Greene JA; DeVecchio JL; Gould MP; Auletta JJ; Heinzel FP J Immunol; 2006 May; 176(10):5995-6003. PubMed ID: 16670308 [TBL] [Abstract][Full Text] [Related]
6. Type I interferon as a stimulus for cross-priming. Le Bon A; Tough DF Cytokine Growth Factor Rev; 2008 Feb; 19(1):33-40. PubMed ID: 18068417 [TBL] [Abstract][Full Text] [Related]
7. The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity. Santini SM; Di Pucchio T; Lapenta C; Parlato S; Logozzi M; Belardelli F J Interferon Cytokine Res; 2002 Nov; 22(11):1071-80. PubMed ID: 12513906 [TBL] [Abstract][Full Text] [Related]
8. Interferon-beta expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity. Faul EJ; Wanjalla CN; McGettigan JP; Schnell MJ Virology; 2008 Dec; 382(2):226-38. PubMed ID: 18945463 [TBL] [Abstract][Full Text] [Related]
9. Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-alpha beta and IFN-gamma. Kamath AT; Sheasby CE; Tough DF J Immunol; 2005 Jan; 174(2):767-76. PubMed ID: 15634897 [TBL] [Abstract][Full Text] [Related]
10. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Honda K; Yanai H; Negishi H; Asagiri M; Sato M; Mizutani T; Shimada N; Ohba Y; Takaoka A; Yoshida N; Taniguchi T Nature; 2005 Apr; 434(7034):772-7. PubMed ID: 15800576 [TBL] [Abstract][Full Text] [Related]
12. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C Front Immunol; 2018; 9():79. PubMed ID: 29459858 [TBL] [Abstract][Full Text] [Related]
13. Role of type I interferon in inducing a protective immune response: perspectives for clinical applications. Rizza P; Moretti F; Capone I; Belardelli F Cytokine Growth Factor Rev; 2015 Apr; 26(2):195-201. PubMed ID: 25466627 [TBL] [Abstract][Full Text] [Related]
15. Dendritic cells star in Vancouver. Klechevsky E; Kato H; Sponaas AM J Exp Med; 2005 Jul; 202(1):5-10. PubMed ID: 15998786 [TBL] [Abstract][Full Text] [Related]
16. Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells. Sköld AE; Mathan TSM; van Beek JJP; Flórez-Grau G; van den Beukel MD; Sittig SP; Wimmers F; Bakdash G; Schreibelt G; de Vries IJM Cancer Immunol Immunother; 2018 Sep; 67(9):1425-1436. PubMed ID: 30019146 [TBL] [Abstract][Full Text] [Related]
17. Direct action of type I IFN on NK cells is required for their activation in response to vaccinia viral infection in vivo. Martinez J; Huang X; Yang Y J Immunol; 2008 Feb; 180(3):1592-7. PubMed ID: 18209055 [TBL] [Abstract][Full Text] [Related]
18. Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. Jinushi M; Takehara T; Tatsumi T; Kanto T; Groh V; Spies T; Suzuki T; Miyagi T; Hayashi N J Immunol; 2003 Nov; 171(10):5423-9. PubMed ID: 14607946 [TBL] [Abstract][Full Text] [Related]
19. Modification of TLR-induced activation of human dendritic cells by type I IFN: synergistic interaction with TLR4 but not TLR3 agonists. Walker J; Tough DF Eur J Immunol; 2006 Jul; 36(7):1827-36. PubMed ID: 16783851 [TBL] [Abstract][Full Text] [Related]
20. IFN-alpha in the generation of dendritic cells for cancer immunotherapy. Santini SM; Lapenta C; Santodonato L; D'Agostino G; Belardelli F; Ferrantini M Handb Exp Pharmacol; 2009; (188):295-317. PubMed ID: 19031032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]